Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...

The Autism Diagnostic Interview-Revised (ADI-R) is one of the most widely used and thoroughly researched caregiver interview ...

Cloudflare has set a 2029 deadline for full post-quantum security, prioritizing authentication over encryption to counter ...

Google published a research blog post on Tuesday about a new compression algorithm for AI models. Within hours, memory stocks were falling. Micron dropped 3 per cent, Western Digital lost 4.7 per cent ...

Organizations of all sizes in all industries face a monumental project of migrating to post-quantum cryptography (PQC) to address the risk of adversaries using quantum computing to intercept sensitive ...

President Donald Trump on Tuesday shared a new rendering of the planned White House ballroom, touting the project as a historic addition he said would "serve our Country well" for "Centuries into the ...

She is soft-spoken, graceful and strikingly young, yet her voice carries both poise and pain. Passionate about women’s rights, 19-year-old Whitney Sally Akinyi, a student at the University of ...

Jay Soneff has spent his career navigating real estate cycles — booms that feel unstoppable and downturns that expose who’s built to last. A third-generation Denver native and longtime commercial real ...

As movies have morphed from a vibrant public event into a product we watch on our personal screens, film criticism has also been disrupted thanks to apps like Letterboxd. Fortunately, film critic A. S ...

ABSTRACT: Purpose: Biomechanical evidence indicates that enhanced coordination in the proximal-to-distal kinetic chain contributes to smash performance in badminton players. Functional training ...

You chose selected. Each dot here represents a single video about selected. While you’re on the app, TikTok tracks how you interact with videos. It monitors your watch time, the videos you like, the ...

Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed disease progression in patients with HER2-positive metastatic breast cancer, ...